Table 1. HPV infection by age related distribution (n=10,442).
Age (yr) | Negative (n=8,294) | Single-type HPV (n=1,449) | Dual-type HPV* (n=466) | Multi-type HPV† (n=233) | Total HPV infection (n=2,148)‡ |
---|---|---|---|---|---|
≤20 (n=89) | 63 | 5 | 11 | 10 | 26 (29.21) |
21–25 (n=861) | 717 | 92 | 30 | 22 | 144 (16.72) |
26–30 (n=1,749) | 1,502 | 161 | 56 | 30 | 247 (14.12) |
31–35 (n=1,693) | 1,388 | 201 | 72 | 32 | 305 (18.02) |
36–40 (n=1,765) | 1,396 | 271 | 80 | 18 | 369 (20.91) |
41–45 (n=1,853) | 1,455 | 278 | 84 | 36 | 398 (21.48) |
46–50 (n=1,335) | 1,009 | 238 | 60 | 28 | 326 (24.42) |
51–55 (n=537) | 376 | 113 | 32 | 16 | 161 (29.98) |
56–60 (n=284) | 186 | 54 | 24 | 20 | 98 (34.51) |
61–65 (n=164) | 117 | 21 | 11 | 15 | 47 (28.66) |
≥66 (n=112) | 85 | 15 | 6 | 6 | 27 (24.11) |
Values are presented as number (%). Detected by PCR-RDB genotyping, 18 HR-HPV, and 5 LR-HPV subtypes could be analyzed in the population.
HPV, human papillomavirus; HR-HPV, high-risk human papillomavirus; LR-HPV, low-risk human papillomavirus; PCR-RDB, polymerase chain reaction-reverse dot blot.
*Dual-type infection: patients with 2 HPV subtypes infection simultaneously; †Multi-type infection: patients with 3 or more HPV subtypes infection simultaneously; ‡Represented the percent of HPV-positive patients in different age groups.